以质量求发展，以服务铸品牌

护理学报 ›› 2021, Vol. 28 ›› Issue (3): 46-52.doi: 10.16460/j.issn1008-9969.2021.03.046

• 循证护理 • 上一篇    下一篇

急性缺血性脑卒中患者溶栓术后预防出血转化的最佳证据总结

王亚玲, 王冰寒, 张艳, 尹雪, 蒋辛, 熊晓明, 黎华丽   

  1. 华中科技大学同济医学院附属协和医院 神经内科,湖北 武汉 430000
  • 收稿日期:2020-11-07 发布日期:2021-03-12
  • 通讯作者: 张艳（1972-）,女,湖北武汉人,本科学历,副主任护师,科护士长。
  • 作者简介:王亚玲（1982-）,女,湖北武汉人,本科学历,主管护师,护士长。
  • 基金资助:
    湖北省卫生计生委面上项目（WJ2017M201）

Best Evidence Summary for Prevention of Hemorrhagic Transformation after Thrombolysis in Patients with Acute Ischemic Stroke

WANG Ya-ling, WANG Bing-han, ZHANG Yan, YIN Xue, JIANG Xin, XIONG Xiao-ming, LI Hua-li   

  1. Dept. of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430000, China
  • Received:2020-11-07 Published:2021-03-12

PDF (PC)

204

赞

摘要： 目的 选取国内外急性缺血性脑卒中溶栓术后患者预防出血转化的相关证据,并对最佳证据进行总结,为护理人员降低脑梗死溶栓术后出血转化提供参考。方法 使用计算机检索Cochrane Library、JBI、BMJ、PubMed、Up To Date、NGC、GIN、SIGN、NZGG、NICE、RNAO、中国知网、维普、万方数据库、中国生物医学数据库,并检索了美国心脏学会/美国卒中学会网站、欧洲卒中组织网站、加拿大卒中网站,从中遴选出符合纳入标准的文献。由2名研究员对文献质量进行独立评价、证据提取和证据综合。结果 共纳入17篇文献,其中指南9篇,系统评价5篇,专家共识/立场声明3篇。从 17 篇文献中共提取了 26 条证据,综合成 7 个维度分别是危险因素、病情监测、血压管理、症状识别、对症处理、药物管理、饮食管理。结论 要以基于循证的标准化预防策略解决急性脑梗死溶栓后出血转化的问题,应用证据时需结合我国国情、临床实际和患者意愿,有针对性地选择证据,促进最佳证据应用于急性缺血性脑卒中溶栓术后出血转化的预防和管理,从而降低脑梗死溶栓术后出血转化发生率,促进护理质量的持续改进,改善患者的临床结局,提升患者的满意度。

关键词: 急性缺血性脑卒中, 溶栓, 出血转化, 症状性脑出血, 循证护理

Abstract: Objective To summarize the best evidence for the prevention of hemorrhagic transformation after thrombolysis in patients with acute ischemic stroke and to provide reference for nursing staff to reduce the incidence of hemorrhagic transformation after thrombolysis of stroke. Methods We searched Cochrane Library, JBI, BMJ, PubMed, UpToDate, NGC, GIN, SIGN, NZGG, NICE, RNAO, CNKI, Vip Datebase, Wanfang Datebase, CBM and AHA/ASA, ESO and Canadian Stroke Best Practices for eligible literature. Two researchers independently appraised articles, and extracted data from eligible studies. Results Seventeen articles were enrolled, including 9 guidelines, 5 systematic reviews, 3 expert consensuses/position statement. Totally 26 items of best evidence were summarized from seven aspects：risk factors, condition monitoring, blood pressure management, symptom identification, symptomatic treatment, medication management and diet management. Conclusion Evidence-based standardized prevention strategy should be adopted for the prevention of hemorrhagic transformation after thrombolysis of acute ischemic stroke. It is necessary to select evidence according to the national conditions, clinical practice and patients' wishes. When applying evidence, the best evidence should be applied to the prevention and management of haemorrhage transformation after thrombolysis of acute ischemic stroke, so as to reduce the incidence of hemorrhagic transformation, promote the continuous improvement of nursing quality, the clinical outcome of patients and the satisfaction of patients.

Key words: acute ischemic stroke, thrombolysis, hemorrhagic transformation, symptomatic intracerebral hemorrhage, evidence-based nursing

中图分类号: 

  • R473.74
[1] Wang W,Jiang B,Sun H,et al.Prevalence,Incidence,and Mortality of Stroke in China:Results from a Nationwide Population.Based Survey of 480 687 Adults[J]. Circulation,2017,135(8):759-771.DOI:10.1161/CIRCULATIONAHA.116.025250.
[2] Wang D, Liu J,Liu M,et a1.Patterns of Stroke Between Universitv Hospitals and Nonuniversity Hospitals in Mainland China:Prospective Muhicenter Hospital-based Registry Study[J]. World Neurosurg,2017,98(2):258-265. DOI:10.1016/j.wneu.2016.11.006.
[3] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志,2018, 51(9):666-682.DOI:10.3760/cma.j.issn.1006-7876.2018.09.004.
[4] Kernan WN, Ovbiagele B, Black H R, et al.Guidelines for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association[J]. Stroke,2014,45(7):2160-2236. DOI:10.1161/STR.0000000000000024.
[5] Coutts SB, Wein TH, Lindsay MP, et al.Canadian Stroke Best Practice Recommendations: Secondary Prevention of Stroke Guidelines, Update 2014[J]. Int J Stroke, 2014, 23(10):924-940. DOI:10.1111/ijs.12439.
[6] Minematsu K.Intravenous Rt-Pa Therapy: Current Status and Extending Therapeutic Time Window in Japan[J]. Rinsho Shinkeigaku, 2013, 53(11):1163-1165. DOI:10.5692/clinicalneurol.53.1163.
[7] Yaghi S, Willey JZ, Cucchiara B, et al.Treatment and Outcome of Hemorrhagic Transformation After Intravenous Alteplase in Acute Ischemic Stroke: A Scientific Statement for Healthcare Professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2017, 48(12): e343-e361. DOI:10.1161/STR.0000000000000152.
[8] Seet RC, Rabinstein AA.Symptomatic Intracranial Hemorrhage Following Intravenous Thrombolysis for Acute Ischemic Stroke: A Critical Review of Case Definitions[J].Cerebrovasc Dis, 2012, 34(2):106-114. DOI:10.1159/000339675.
[9] Dharmasaroja PA, Dharmasaroja P, Muengtaweepongsa S.Outcomes of Thai Patients with Acute Ischemic Stroke after Intravenous Thrombolysis[J]. J Neurol Sci,2011, 300(1-2): 74-77. DOI:10.1016/j.jns.2010.09.029.
[10] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性脑梗死后出血转化诊治共识2019[J].中华神经科杂志, 2019, 52(4):252-265.DOI:10.3760/cma.j.issn.1006-7876.2018.09.004.
[11] Mehta RH, Cox M, Smith EE, et al.Race/Ethnic Differences in the Risk of Hemorrhagic Complications Among Patients with Ischemic Stroke Receiving Thrombolytic Therapy[J]. Stroke, 2014, 45(8):2263-2269. DOI:10.1161/STROKEAHA.114.005019.
[12] Hao Y, Yang D, Wang H, et al.Predictors for Symptomatic Intracranial Hemorrhage after Endovascular Treatment of Acute Ischemic Stroke[J]. Stroke, 2017, 48(5):1203-1209. DOI:10.1161/STROKEAHA.116.016368.
[13] Lansberg MG, O'Donnell MJ, Khatri P, et al. Antithrombotic and Thrombolytic Therapy for Ischemic Stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-based Clinical Practice Guidelines[J]. Chest, 2012, 141(2 Suppl): e601S-e636S. DOI:10.1378/chest.11-2302.
[14] Steiner T, Al-Shahi Salman R, Beer R, et al. European Stroke Organisation (ESO) Guidelines for the Management of Spontaneous Intracerebral Hemorrhage[J]. Int J Stroke,2014, 9(7):840-855. DOI:10.1111/ijs.12309.
[15] Casaubon LK, Boulanger JM, Glasser E, et al.Canadian Stroke Best Practice Recommendations: Acute Inpatient Stroke Care Guidelines,Update 2015[J]. Int J Stroke, 2016, 11(2):239-252. DOI:10.1177/1747493015622461.
[16] Aromataris E, Fernandez R, Godfrey CM, et al.Summarizing Systematic Reviews: Methodological Development, Conduct and Reporting of an Umbrella Review Approach[J].Int J Evid Based Healthc, 2015, 13(3):132-140.DOI:10.1097/XEB.0000000000000055.
[17] Brouwers MC, Kho ME, Browman GP, et al.AGREE II: Advancing Guideline Development, Reporting and Evaluation in Healthcare[J]. Can Med Assoc J, 2010, 182(18): E839-E842. DOI:10.1503/cmaj.090449.
[18] Shea BJ, Reeves BC, Wells G, et al.AMSTAR 2:A Critical Appraisal Tool for Systematic Reviews That Include Randomised or Non-randomised Studies of Healthcare Interventions or Both[J]. BMJ, 2017(358):j4008. DOI:10.1136/bmj.j4008.
[19] The Joanna Briggs Institute. Joanna Briggs Institute Reviewers' Manual:2016edition[M].Australia:The Joanna Briggs Institute, 2016.
[20] 王春青,胡雁.JBI证据预分级及证据推荐级别系统(2014版)[J].护士进修杂志,2015,30(11):964-967.
[21] 刘云访,喻姣花,李素云,等. ICU成人患者气管插管非计划性拔管预防及管理的证据总结[J]. 护理学报,2020,27(3):43-48.DOI:10.16460/j.issn1008-9969.2020.03.043.
[22] 李佳梅,陈鸿芳,刘宁,等. 脑梗死偏瘫患者良肢位管理的最佳证据总结[J]. 护理学报,2019,26(24):22-27.DOI:10.16460/j.issn1008-9969.2019.24.022.
[23] Liu L, Ding J, Leng X, et al.Guidelines for Evaluation and Management of Cerebral Collateral Circulation in Ischaemic Stroke 2017[J]. Stroke Vasc Neurol, 2018, 3(3):118-130. DOI:10.1136/svn-2017-000135.
[24] Furie KL, Jayaraman MV.2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke[J]. Stroke, 2018, 49(3):509-510. DOI:10.1161/STROKEAHA.118.020176.
[25] Tyrrell P, Swain S, Rudd A.NICE Guideline on Acute Stroke and TIA: Commentary[J]. Heart, 2009, 95(10):843-845. DOI:10.1136/hrt.2009.167684.
[26] Hemphill JC, Greenberg SM, Anderson CS, et al.Guidelines for the Management of Spontaneous Intracerebral Hemorrhage:A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association[J]. Stroke,2015,46(7):2032-2060. DOI:10.1161/STR.0000000000000069.
[27] Kernan WN, Ovbiagele B, Black HR, et al.Guidelines for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association Published Correction Appears in Stroke[J]. Stroke, 2014, 45(7):2160-2236. DOI:10.1161/STR.0000000000000024.
[28] Prabhakaran S, Ruff I, Bernstein RA.Acute Stroke Intervention: A Systematic Review[J]. JAMA, 2015, 313(14):1451-1462. DOI:10.1001/jama.2015.3058.
[29] Appleton JP, Sprigg N, Bath PM.Blood Pressure Management in Acute Stroke[J]. Stroke Vasc Neurol, 2016, 1(2):72-82. DOI:10.1136/svn-2016-000020.
[30] Luo SY, Zhang M, Zeng WT, et al.Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Receiving Antiplatelet Therapy: A Systematic Review and Meta-analysis of 19 Studies[J]. J Am Heart Assoc, 2016,5(5):e003242. DOI:10.1161/JAHA.116.003242.
[31] Wardlaw JM, Murray V, Berge E, et al.Thrombolysis for Acute Ischaemic Stroke(Review)[J].Cochrane Database of Systematic Reviews,2014(7):1-145.DOI:10.1002/14651858.CD000213.pub3.
[32] Whiteley WN, Slot KB, Fernandes P, et al.Risk Factors for Intracranial Hemorrhage in Acute Ischemic Stroke Patients Treated with Recombinant Tissue Plasminogen Activator: A Systematic Review and Meta-analysis of 55 Studies[J]. Stroke, 2012, 43(11):2904-2909. DOI:10.1161/STROKEAHA.112.665331.
[33] Demaerschalk BM, Kleindorfer DO, Adeoye OM, et al.Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke[J]. Stroke,2016,47(2):581-641.DOI:10.1161/STR.0000000000000086.
[34] 吴娅,刘承春,李玮,等. 5种评分系统对不同时间窗急性脑梗死静脉溶栓后出血转化风险预测差异的比较研究[J]. 第三军医大学学报,2017,39(17):1744-1749.DOI:10.16016 /j.1000-5404.201702008.
[35] Yaghi S, Boehme AK, Dibu J, et al.Treatment and Outcome of Thrombolysis-related Hemorrhage: A Multicenter Retrospective Study[J]. JAMA Neurol, 2015,72(12):1451-1457.DOI:10.1001/jamaneurol.2015.2371.
[36] Hacke W, Kaste M, Fieschi C, et al.Randomised Double-blind Placebo-controlled Trial of Thrombolytic Therapy with Intravenous Alteplase in Acute Ischaemic Stroke (ECASS II).Second European-australasian Acute Stroke Study Investigators[J]. Lancet,1998, 352(9136):1245-1251.DOI:10.1016/s0140-6736(98)08020-9.
[37] Wahlgren N, Ahmed N, Eriksson N, et al.Multivariable Analysis of Outcome Predictors and Adjustment of Main Outcome Results to Baseline Data Profile in Randomized Controlled Trials: Safe Implementation of Thrombolysis in Stroke-monitoring Study (SITS-MOST)[J]. Stroke,2008,39(12):3316-3322. DOI:10.1161/STROKEAHA.107.510768.
[38] Hao Y, Yang D, Wang H, et al.Predictors for Symptomatic Intracranial Hemorrhage after Endovascular Treatment of Acute Ischemic Stroke[J]. Stroke, 2017, 48(5):1203-1209.DOI:10.1161/STROKEAHA.11.016368.
[39] Zaidat OO, Castonguay AC, Gupta R, et al.North American Solitaire Stent Retriever Acute Stroke Registry: Post-marketing Revascularization and Clinical Outcome Results[J]. J Neurointerv Surg,2018, 10(Suppl 1):i45-i49.DOI:10.1136/neurintsurg-2013-010895.rep.
[1] 马莹, 叶君荣, 黄昭君, 夏志春, 徐丹, 邓爱萍, 刘名河, 罗斯莉, 张建龙. 基于循证构建精神科护理质量敏感性指标[J]. 护理学报, 2020, 27(9): 27-32.
[2] 吕云霞, 冯少娟, 李丹枫, 吴宣霖, 陈彦球, 陈柳妹, 刘洁, 黄洁莹, 刘正伟. 儿童扁桃体切除术后疼痛管理的最佳证据总结[J]. 护理学报, 2020, 27(7): 38-43.
[3] 周芬. 患者及公众参与临床实践指南构建及其方法的研究进展[J]. 护理学报, 2020, 27(5): 14-17.
[4] 周士萍, 吴金球, 石慧, 肖思凡, 黄蓉, 程云. 经尿道前列腺切除术后膀胱冲洗最佳证据的应用研究[J]. 护理学报, 2020, 27(5): 18-21.
[5] 张娟, 黄蓓蓓, 余天浩, 刘夕珍, 顾静. 基于医疗失效模式与效应分析模型的急性缺血性脑卒中患者院内急救流程优化[J]. 护理学报, 2020, 27(4): 16-20.
[6] 张煜, 张春艳, 金玉, 王淑芹, 董亮, 万娜, 贾燕瑞, 高凤莉. 内科危重症患者深静脉血栓预防审查指标的制定及障碍因素分析[J]. 护理学报, 2020, 27(4): 37-41.
[7] 王焕焕, 程湘玮, 王培红, 丁颖, 周英凤, 张纹, 熊彩霞, 吕永利, 屠凤鸣. 妊娠期糖尿病产妇分娩新生儿低血糖管理的最佳证据总结[J]. 护理学报, 2020, 27(3): 31-36.
[8] 刘云访, 喻姣花, 李素云, 赵诗雨, 晏蓉, 滕芬. ICU成人患者气管插管非计划性拔管预防及管理的证据总结[J]. 护理学报, 2020, 27(3): 43-48.
[9] 谭静, 韩江全, 胡春婷, 廉民学, 罗红波, 李妍, 刘宁. 脑卒中后抑郁管理的最佳证据总结[J]. 护理学报, 2020, 27(23): 42-48.
[10] 史博慧, 吕爱莉, 王恋, 郭萍利, 马晓霞, 齐晶. 乳腺癌术后上肢淋巴水肿预防策略的证据总结[J]. 护理学报, 2020, 27(22): 32-38.
[11] 李苗苗, 安李一, 陆巍, 王娟, 徐鹏飞. Ⅳ型心肾综合征腹膜透析患者容量管理的最佳证据总结[J]. 护理学报, 2020, 27(22): 39-44.
[12] 王兆北, 陈玲, 李红, 石磊, 李永宁, 陈义刚. 肝移植患者术后早期活动管理的证据总结[J]. 护理学报, 2020, 27(21): 46-50.
[13] 王海燕, 王丽, 张超庭, 孙祝华, 邹丹凤, 李玉梅, 吴红伦, 朱碧丽. 腰麻术后最佳体位管理策略的证据总结[J]. 护理学报, 2020, 27(20): 32-37.
[14] 谢洁莹, 周望梅, 徐慧颖, 汪琴, 李杨华, 张艳群. 急性胰腺炎患者早期肠内营养最佳证据总结[J]. 护理学报, 2020, 27(19): 29-34.
[15] 林俏, 张广清, 刘梅娟, 黄颖, 刘丹阳, 刘玉萍, 邢同印, 陈继华. 成人结肠镜检查前肠道准备的最佳证据总结[J]. 护理学报, 2020, 27(16): 28-34.
Viewed
Full text


Abstract

Cited
  Shared   
[1] 王佳瑞, 李彦丽. 腕踝针干预寒湿凝滞型原发性痛经患者的效果观察[J]. 护理学报, 2021, 28(1): 1 -3 .
[2] 杜金磊, 陈志美, 龚莉, 宋杰, 王翔, 邹晓月. 气管拔管后嗓音障碍患者系统康复训练的效果观察[J]. 护理学报, 2021, 28(1): 4 -8 .
[3] 梁红宽, 罗蔼, 宋瑜, 肖东. 降低扫描式葡萄糖监测系统传感器非预期更换率的品管圈实践[J]. 护理学报, 2021, 28(1): 9 -12 .
[4] 杨芳, 杨艳, 贺琳晰. OEC管理模式在新型冠状病毒核酸检测采集中心护理管理中的应用[J]. 护理学报, 2021, 28(1): 13 -16 .
[5] 赵明曦, 孙建华, 李若祎, 侯锦, 李尊柱, 罗红波, 奉爱萍, 李欣, 李奇. 床旁超声在重症患者肠内营养的应用进展[J]. 护理学报, 2021, 28(1): 17 -21 .
[6] 姚露, 陈雪萍, 刘欣, 陈姬, 汪梦鑫. 运动传感设备在衰弱老年人中的应用进展[J]. 护理学报, 2021, 28(1): 22 -26 .
[7] 汪梦月, 蒋园园, 陈妍, 盛少婷. 老年综合评估对预防老年患者护理不良事件发生的Meta分析[J]. 护理学报, 2021, 28(1): 27 -32 .
[8] 江丽玲, 詹梦梅, 黄秋霞, 李立群, 张淑, 龚晶晶, 王建宁. 乳腺癌患者性生活体验质性研究的Meta整合[J]. 护理学报, 2021, 28(1): 33 -37 .
[9] 路莉静, 孟爱凤, 程芳, 邾萍, 智晓旭, 汤琳, 王鹏程. 乳腺癌患者就医延迟原因质性研究的Meta整合[J]. 护理学报, 2021, 28(1): 38 -44 .
[10] 涂惠琼, 龙秀红, 沈琴庆. 148例先天性心脏病患儿术后主要照顾者的居家康复护理需求现状及影响因素分析[J]. 护理学报, 2021, 28(1): 45 -50 .